SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

West Pharmaceutical Services Inc (New York Stock Exchange:WST)

US · Delayed Price · Currency is USD
366.48-6.16 (-1.65%)
 
Market Cap25.79B+36.8%
Revenue (ttm)3.33B+12.4%
Net Income564.90M+15.8%
EPS7.82+17.1%
Shares Out70.38M
PE Ratio46.57
Forward PE36.61
Dividend$0.88(0.24%)
Ex-Dividend DateJul 29, 2026
Volume437,984
Open371.66
Previous Close372.64
Day's Range365.30 - 374.79
52-Week Range223.83 - 386.00
Beta1.13
AnalystsBuy
Price Target419.50(+14.47%)
Earnings DateOct 22, 2026
Insider Score
––Not scored
WST Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About WST

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Address
530 Herman O. West Drive, Exton, PA, 19341-1147, US
Market Cap
25.79 billion
Employees
10,800
Industrial Classification
Medical - Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$5.44M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-1.65%
5 Days
+0.48%
1 Month
+8.51%
6 Months
+37.81%
1 Year
+36.78%

$WST stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of WST by members of U.S. Congress

PoliticianTypeTraded
Jared MoskowitzHouse / DSale$1.00K – $15.00KFeb 13, 2025
Jared MoskowitzHouse / DSale$1.00K – $15.00KFeb 12, 2025
Jared MoskowitzHouse / DSale$1.00K – $15.00KNov 8, 2024
Jared MoskowitzHouse / DSale$1.00K – $15.00KNov 7, 2024
Jared MoskowitzHouse / DPurchase$1.00K – $15.00KDec 28, 2023
Jared MoskowitzHouse / DPurchase$1.00K – $15.00KDec 27, 2023
Jared MoskowitzHouse / DPurchase$1.00K – $15.00KJul 14, 2023
Jared MoskowitzHouse / DPurchase$1.00K – $15.00KJul 13, 2023

Recently reported changes in WST holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by WST's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

WST Estimated quarterly lobbying spending

Source: U.S. Senate LDA

WST Revenue by Segment or Geography

$872.30MTotal
SegmentRevenue% of All
Proprietary Products$722.60M82.84%
West Vantage$149.70M17.16%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New WST patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to WST from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in WST

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$765.75M
VOOVanguard S&P 500 ETF$640.24M
VOVanguard Morningstar Mid-Cap ETF$521.26M
IVViShares Core S&P 500 ETF$349.46M
SPYState Street SPDR S&P 500 ETF$320.57M
VUGVanguard Morningstar Growth ETF$318.14M

Estimated from each fund’s disclosed top holdings × AUM

WST Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for WST is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from WST’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
6
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.